AAPL323.81+8.47 (+2.69%) ▲|ABBV252.61+1.70 (+0.68%) ▲|ABT103.82-1.42 (-1.34%) ▼|ACN177.64+1.84 (+1.05%) ▲|ADBE249.37-5.49 (-2.15%) ▼|AMAT457.63-11.22 (-2.39%) ▼|AMD506.42-14.68 (-2.82%) ▼|AMGN382.73-8.54 (-2.18%) ▼|AMT172.86-2.57 (-1.47%) ▼|AMZN252.26-0.15 (-0.06%) ▼|AVGO362.82-1.56 (-0.43%) ▼|AXP320.69-1.12 (-0.35%) ▼|BA206.24-0.18 (-0.09%) ▼|BAC62.40-0.28 (-0.44%) ▼|BKNG175.74+2.31 (+1.33%) ▲|BLK1,069.35-2.69 (-0.25%) ▼|BMY63.95-0.46 (-0.71%) ▼|BNY162.29-0.22 (-0.14%) ▼|BRK-B504.93-1.79 (-0.35%) ▼|C137.99+0.19 (+0.14%) ▲|CAT802.09-13.48 (-1.65%) ▼|CL88.23+0.20 (+0.23%) ▲|CMCSA25.15+0.56 (+2.26%) ▲|COF207.55-3.31 (-1.57%) ▼|COP137.88+1.35 (+0.99%) ▲|COST899.44-3.16 (-0.35%) ▼|CRM244.04-0.12 (-0.05%) ▼|CSCO108.19-1.24 (-1.13%) ▼|CVS95.24-0.14 (-0.15%) ▼|CVX213.52-0.30 (-0.14%) ▼|DE674.07-3.14 (-0.46%) ▼|DHR201.69-3.17 (-1.55%) ▼|DIS104.89+0.71 (+0.68%) ▲|DUK119.64-0.80 (-0.66%) ▼|EMR147.52-2.83 (-1.88%) ▼|FDX311.06+1.87 (+0.60%) ▲|GD353.48+0.81 (+0.23%) ▲|GE322.87-2.55 (-0.78%) ▼|GEV925.75-25.29 (-2.66%) ▼|GILD145.05-0.60 (-0.41%) ▼|GM85.49+1.73 (+2.07%) ▲|GOOG329.31+0.93 (+0.28%) ▲|GOOGL331.57+0.92 (+0.28%) ▲|GS1,020.01-8.77 (-0.85%) ▼|HD305.21-5.24 (-1.69%) ▼|HON202.18-2.76 (-1.34%) ▼|IBM236.33-3.62 (-1.51%) ▼|INTC101.37-4.87 (-4.58%) ▼|INTU312.62-1.32 (-0.42%) ▼|ISRG360.15+6.91 (+1.96%) ▲|JNJ266.75-0.34 (-0.13%) ▼|JPM352.80-1.91 (-0.54%) ▼|KO88.14+0.59 (+0.67%) ▲|LIN461.61-5.05 (-1.08%) ▼|LLY1,126.61+2.40 (+0.21%) ▲|LMT528.21+3.75 (+0.72%) ▲|LOW195.79-2.82 (-1.42%) ▼|LRCX300.79-15.05 (-4.77%) ▼|MA564.19-3.32 (-0.58%) ▼|MCD253.70+0.22 (+0.08%) ▲|MDLZ62.26-0.16 (-0.26%) ▼|MDT91.36-0.53 (-0.58%) ▼|META649.75-3.94 (-0.60%) ▼|MMM162.34-2.06 (-1.25%) ▼|MO68.67+0.78 (+1.14%) ▲|MRK145.04-2.50 (-1.69%) ▼|MS213.84-1.51 (-0.70%) ▼|MSFT492.38+0.73 (+0.15%) ▲|MU979.91-47.87 (-4.66%) ▼|NEE82.55-0.10 (-0.12%) ▼|NFLX75.99-0.05 (-0.06%) ▼|NKE36.81-0.54 (-1.45%) ▼|NOW131.94+0.83 (+0.63%) ▲|NVDA218.46-5.21 (-2.33%) ▼|ORCL156.58-5.05 (-3.12%) ▼|PEP136.89+0.20 (+0.15%) ▲|PFE27.51-0.28 (-0.99%) ▼|PG142.91+0.27 (+0.19%) ▲|PLTR166.14-3.39 (-2.00%) ▼|PM189.15+3.44 (+1.85%) ▲|QCOM180.12+3.72 (+2.11%) ▲|RTX197.41-0.14 (-0.07%) ▼|SBUX99.65-0.39 (-0.39%) ▼|SCHW106.74+0.20 (+0.18%) ▲|SO87.91-0.44 (-0.49%) ▼|SPG205.94+1.41 (+0.69%) ▲|T25.53+0.38 (+1.49%) ▲|TMO603.01-2.68 (-0.44%) ▼|TMUS175.87-1.47 (-0.83%) ▼|TSLA366.60-1.21 (-0.33%) ▼|TXN259.47-2.12 (-0.81%) ▼|UBER72.45+1.37 (+1.93%) ▲|UNH390.92-2.14 (-0.54%) ▼|UNP284.23-0.52 (-0.18%) ▼|UPS100.08+0.86 (+0.86%) ▲|USB62.01-0.11 (-0.17%) ▼|V366.59-0.80 (-0.22%) ▼|VZ49.92+0.18 (+0.36%) ▲|WFC88.94-0.74 (-0.82%) ▼|WMT105.89+0.06 (+0.05%) ▲|XOM165.42+1.19 (+0.72%) ▲|AAPL323.81+8.47 (+2.69%) ▲|ABBV252.61+1.70 (+0.68%) ▲|ABT103.82-1.42 (-1.34%) ▼|ACN177.64+1.84 (+1.05%) ▲|ADBE249.37-5.49 (-2.15%) ▼|AMAT457.63-11.22 (-2.39%) ▼|AMD506.42-14.68 (-2.82%) ▼|AMGN382.73-8.54 (-2.18%) ▼|AMT172.86-2.57 (-1.47%) ▼|AMZN252.26-0.15 (-0.06%) ▼|AVGO362.82-1.56 (-0.43%) ▼|AXP320.69-1.12 (-0.35%) ▼|BA206.24-0.18 (-0.09%) ▼|BAC62.40-0.28 (-0.44%) ▼|BKNG175.74+2.31 (+1.33%) ▲|BLK1,069.35-2.69 (-0.25%) ▼|BMY63.95-0.46 (-0.71%) ▼|BNY162.29-0.22 (-0.14%) ▼|BRK-B504.93-1.79 (-0.35%) ▼|C137.99+0.19 (+0.14%) ▲|CAT802.09-13.48 (-1.65%) ▼|CL88.23+0.20 (+0.23%) ▲|CMCSA25.15+0.56 (+2.26%) ▲|COF207.55-3.31 (-1.57%) ▼|COP137.88+1.35 (+0.99%) ▲|COST899.44-3.16 (-0.35%) ▼|CRM244.04-0.12 (-0.05%) ▼|CSCO108.19-1.24 (-1.13%) ▼|CVS95.24-0.14 (-0.15%) ▼|CVX213.52-0.30 (-0.14%) ▼|DE674.07-3.14 (-0.46%) ▼|DHR201.69-3.17 (-1.55%) ▼|DIS104.89+0.71 (+0.68%) ▲|DUK119.64-0.80 (-0.66%) ▼|EMR147.52-2.83 (-1.88%) ▼|FDX311.06+1.87 (+0.60%) ▲|GD353.48+0.81 (+0.23%) ▲|GE322.87-2.55 (-0.78%) ▼|GEV925.75-25.29 (-2.66%) ▼|GILD145.05-0.60 (-0.41%) ▼|GM85.49+1.73 (+2.07%) ▲|GOOG329.31+0.93 (+0.28%) ▲|GOOGL331.57+0.92 (+0.28%) ▲|GS1,020.01-8.77 (-0.85%) ▼|HD305.21-5.24 (-1.69%) ▼|HON202.18-2.76 (-1.34%) ▼|IBM236.33-3.62 (-1.51%) ▼|INTC101.37-4.87 (-4.58%) ▼|INTU312.62-1.32 (-0.42%) ▼|ISRG360.15+6.91 (+1.96%) ▲|JNJ266.75-0.34 (-0.13%) ▼|JPM352.80-1.91 (-0.54%) ▼|KO88.14+0.59 (+0.67%) ▲|LIN461.61-5.05 (-1.08%) ▼|LLY1,126.61+2.40 (+0.21%) ▲|LMT528.21+3.75 (+0.72%) ▲|LOW195.79-2.82 (-1.42%) ▼|LRCX300.79-15.05 (-4.77%) ▼|MA564.19-3.32 (-0.58%) ▼|MCD253.70+0.22 (+0.08%) ▲|MDLZ62.26-0.16 (-0.26%) ▼|MDT91.36-0.53 (-0.58%) ▼|META649.75-3.94 (-0.60%) ▼|MMM162.34-2.06 (-1.25%) ▼|MO68.67+0.78 (+1.14%) ▲|MRK145.04-2.50 (-1.69%) ▼|MS213.84-1.51 (-0.70%) ▼|MSFT492.38+0.73 (+0.15%) ▲|MU979.91-47.87 (-4.66%) ▼|NEE82.55-0.10 (-0.12%) ▼|NFLX75.99-0.05 (-0.06%) ▼|NKE36.81-0.54 (-1.45%) ▼|NOW131.94+0.83 (+0.63%) ▲|NVDA218.46-5.21 (-2.33%) ▼|ORCL156.58-5.05 (-3.12%) ▼|PEP136.89+0.20 (+0.15%) ▲|PFE27.51-0.28 (-0.99%) ▼|PG142.91+0.27 (+0.19%) ▲|PLTR166.14-3.39 (-2.00%) ▼|PM189.15+3.44 (+1.85%) ▲|QCOM180.12+3.72 (+2.11%) ▲|RTX197.41-0.14 (-0.07%) ▼|SBUX99.65-0.39 (-0.39%) ▼|SCHW106.74+0.20 (+0.18%) ▲|SO87.91-0.44 (-0.49%) ▼|SPG205.94+1.41 (+0.69%) ▲|T25.53+0.38 (+1.49%) ▲|TMO603.01-2.68 (-0.44%) ▼|TMUS175.87-1.47 (-0.83%) ▼|TSLA366.60-1.21 (-0.33%) ▼|TXN259.47-2.12 (-0.81%) ▼|UBER72.45+1.37 (+1.93%) ▲|UNH390.92-2.14 (-0.54%) ▼|UNP284.23-0.52 (-0.18%) ▼|UPS100.08+0.86 (+0.86%) ▲|USB62.01-0.11 (-0.17%) ▼|V366.59-0.80 (-0.22%) ▼|VZ49.92+0.18 (+0.36%) ▲|WFC88.94-0.74 (-0.82%) ▼|WMT105.89+0.06 (+0.05%) ▲|XOM165.42+1.19 (+0.72%) ▲|
30.6 C
New York
Thursday, September 10, 2026

Tag: sciences

newssourceFORcompanyinformationcontent1releasesmarket

Dr. Elad Yossefi and Dr. Tal Yossefi Introduce Tech-Enhanced Dental Services in Norwalk

Advanced Dental Center Expands Full-Mouth Restoration and Gum Disease Treatment with Modern Tools 
Advanced Dental Center Expands Full-Mouth Restoration and Gum Disease Treatment with Modern Tools

Enzo Biochem Reports Third Quarter Fiscal Year 2025 Results

FARMINGDALE, N.Y., June 16, 2025 (GLOBE NEWSWIRE) -- Enzo Biochem, Inc. (OTCQX: ENZB) (“Enzo” or the “Company”) today announced financial results for the fiscal third quarter ended April 30, 2025.

ANAVEX SHAREHOLDER ALERT: Kaskela Law LLC Announces Investigation of Anavex Life Sciences Corp. (NASDAQ: AVXL) and Encourages Long-Term Investors to Contact the Firm

PHILADELPHIA, June 16, 2025 (GLOBE NEWSWIRE) -- The law firm of Kaskela Law LLC announces that it is investigating potential breach of fiduciary duty claims concerning Anavex Life Sciences Corp. (NASDAQ: AVXL) (“Anavex”) on behalf of the company’s long-term shareholders. 

Chronic Lower Back Pain Market to Expand Significantly During the Forecast Period (2025-2034) with Game-Changing Therapies | DelveInsight

The overall chronic lower back pain market is expected to boost with the expected launch of emerging therapies such as SP-102 (Scilex Holding), Rexlemestrocel-L...

The Inner Circle acknowledges, Lindsay M. Price as a Pinnacle Lifetime Member

SEABROOK, Texas, June 16, 2025 /PRNewswire/ -- Prominently featured in The Inner Circle, Lindsay M. Price is acknowledged as a Pinnacle Lifetime Member for...

Rescale to Provide CAE Hub on NVIDIA’s European Industrial AI Cloud to Expand Access to GPU-Accelerated Digital Engineering Simulation

Rescale's CAE Hub Will Provide European Engineers and Scientists with Leading-Edge Computing Resources for Digital Simulation and Industrial AI SAN FRANCISCO, June 16, 2025 /PRNewswire/...

Perfusion Medical Announces Scholarship from Virginia Bio to Participate in 2025 BIO International Convention

RESTON, Va., June 16, 2025 /PRNewswire/ -- Perfusion Medical, an emerging biopharmaceutical company developing a pipeline of life-saving, acute cardiovascular therapies to transform intensive...

NRx Pharmaceuticals, Inc. (NASDAQ: NRXP) and HOPE Therapeutics, Inc. Announce Strategic Investor Relations Partnership with astr partners

WILMINGTON, Del., June 16, 2025 /PRNewswire/ -- NRx Pharmaceuticals, Inc. (Nasdaq: NRXP) ("NRx Pharmaceuticals", "NRx" or the "Company"), a clinical-stage biopharmaceutical company, and HOPE...

HELP Therapeutics and China Resources Sanjiu Announce Strategic Partnership to Co-Develop and Commercialize HiCM-188 for Advanced Heart Failure

NANJING, China, June 16, 2025 /PRNewswire/ -- HELP Therapeutics, a global leader in regenerative medicine, and China Resources Sanjiu Pharmaceutical Company, one of China's largest...

GLOBAL MANCOZEB SUMMIT: ADDRESSING ITS CRUCIAL ROLE IN CROP PROTECTION AHEAD OF EU COURT HEARING

LONDON, June 16, 2025 /PRNewswire/ -- UPL Corporation Ltd. (UPL Corp) - part of UPL Group Company (NSE: UPL) & (BSE: 512070) (LSE: UPL), a...

ArkBio’s New Drug Application for ADHD Therapeutic Azstarys Accepted and Granted Priority Review by China NMPA

SHANGHAI, June 15, 2025 /PRNewswire/ -- Shanghai Ark Biopharmaceutical Co., Ltd. ("ArkBio") today announced that the National Medical Products Administration (NMPA) has officially accepted...

EHA 2025 | Multiple Studies Report Encouraging Data of Olverembatinib in Ph+ ALL

ROCKVILLE, Md. and SUZHOU, China, June 15, 2025 (GLOBE NEWSWIRE) -- Ascentage Pharma (NASDAQ: AAPG; HKEX: 6855), a global biopharmaceutical company dedicated to addressing unmet medical needs in cancers, announced that results from 13 studies of its core assets, including the novel drug olverembatinib (HQP1351) and the investigational EED inhibitor APG-5918, have been reported at the 2025 European Hematology Association (EHA) Annual Congress.

Zenobē and Brampton lead CA$4 billion initiative to electrify transit bus fleet in landmark UK-Canada collaboration

CA$4B to fund one of North America's largest single zero-emission bus initiatives Initiative expected to support 5,000 direct and indirect jobs across U.K. and...

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates LNSR, ATAI, ICAD on Behalf of Shareholders

NEW YORK, June 15, 2025 (GLOBE NEWSWIRE) -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to:

- A word from our sponsors -

spot_img

Newsletter Signup

Name(Required)
Email(Required)
Privacy(Required)
This field is for validation purposes and should be left unchanged.
HomeTagsSciences

Explore

Press Releases

News & Opinion

Living

Others

Follow us

© Copyright 2025. BusinessPressWire® / 14 Wall Street New York City NY 10005 +1 888-502-0266 / Disclaimers